Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
precisionmedicineonline15h
At Some Hospitals, Expert Panels Help Guide Anti-Amyloid Drug Decisions for Alzheimer's Patients
These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...
Madison Courier22h
Carr recipient of HC Lilly scholarship
The Harrison County Community Foundation recently announced Samantha Carr as the recipient of the 2025 Lilly Endowment Community Scholarship for Harrison County. Carr is a senior at North Harrison Hig ...
Optimistic Outlook on Foghorn Therapeutics Amid Market Opportunities and Strategic Developments
Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel.Invest with Confidence: Follow ...
PCS Edventures! Increases Board Size and Elects Sean Iddings as Director
PCS Edventures!, Inc., a company involved in providing educational programs, recently made significant changes to its board of directors. On January 22, 2025, the current Board of Directors decided to ...
U.S. Bancorp (NYSE:USB) Announces Appointment of Gunjan Kedia as President and Chief Executive Officer
U.S. Bancorp, a prominent financial institution, has disclosed in an 8-K filing with the Securities and Exchange Commission the appointment of Gunjan Kedia as the President and Chief Executive Officer ...
Healio21h
‘Don’t give up’: Long-term lebrikizumab for AD may benefit initial nonresponders
Long-term treatment with lebrikizumab may be beneficial for patients with atopic dermatitis that were not initially ...